Evidence map›Paper›PMID 40310937›Full record

ArticleScience (New York, N.Y.)2025

Aberrant basal cell clonal dynamics shape early lung carcinogenesis.

Sandra Gómez-López, Ahmed S N Alhendi, Moritz J Przybilla, Ignacio Bordeu, Zoe E Whiteman, Timothy Butler, Maral J Rouhani, Lukas Kalinke, Imran Uddin, Kate E J Otter and 11 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sandra Gómez-LópezLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID 0000-0001-5163-6066
Ahmed S N Alhendi *Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID 0000-0002-1883-2142
Moritz J Przybilla *Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID 0000-0001-5645-9492
Ignacio Bordeu *Departamento de Física, Facultad de Ciencias Físicas y Matemáticas, Universidad de Chile, Santiago, Chile.ORCID 0000-0002-1017-777X
Zoe E WhitemanLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID 0000-0002-1098-6120
Timothy ButlerCancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID 0000-0001-5803-1035
Maral J RouhaniLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Lukas KalinkeLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID 0000-0002-1931-7951
Imran UddinCancer Research UK City of London Centre Single Cell Genomics Facility, UCL Cancer Institute, University College London, London, UK.ORCID 0000-0003-0736-3149
Kate E J OtterLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID 0000-0003-2256-0976
Deepak P ChandrasekharanLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Marta Lebrusant-FernandezPre-Cancer Immunology Laboratory, UCL Cancer Institute, University College London, London, UK.ORCID 0000-0002-1115-1766
Abigail Y L ShurrPre-Cancer Immunology Laboratory, UCL Cancer Institute, University College London, London, UK.
Pascal F DurrenbergerLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID 0009-0002-8041-9225
David A MooreCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Mary FalzonDepartment of Cellular Pathology, University College London Hospitals NHS Trust, London, UK.
James L ReadingPre-Cancer Immunology Laboratory, UCL Cancer Institute, University College London, London, UK.ORCID 0000-0001-5381-978X
Iñigo MartincorenaCancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID 0000-0003-1122-4416
Benjamin D SimonsDepartment of Applied Mathematics and Theoretical Physics, Centre for Mathematical Sciences, University of Cambridge, Cambridge, UK.ORCID 0000-0002-3875-7071
Peter J CampbellCancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID 0000-0002-3921-0510
Sam M JanesLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID 0000-0002-6634-5939

Funding

Cancer Research UK PRCBTP-NOV23/100012Medical Research Council MR/W025051/1Wellcome Trust 107963Wellcome Trust 219478
6 · The paper itself

Abstract

Preinvasive squamous lung lesions are precursors of lung squamous cell carcinoma (LUSC). The cellular events underlying lesion formation are unknown. Using a carcinogen-induced model of LUSC with no added genetic hits or cell type bias, we found that carcinogen exposure leads to non-neutral competition among basal cells, aberrant clonal expansions, and basal cell mobilization along the airways. Ultimately, preinvasive lesions developed from a few highly mutated clones that dominate most of the bronchial tree. Multisite sequencing in human patients confirmed the presence of clonally related preinvasive lesions across distinct airway regions. Our work identifies a transition in basal cell clonal dynamics, and an associated shift in basal cell fate, as drivers of field cancerization in the lung.

Indexed as

CarcinogenesisCarcinoma, Squamous CellCell Transformation, NeoplasticLung NeoplasmsPrecancerous ConditionsAnimalsCarcinogensClone CellsHumansMiceMutationNeoplasms, ExperimentalCarcinogens

Identifiers

PMID40310937
PMCPMC7617789

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.